Market closed
Tiziana Life Sciences Ltd./$TLSA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Ticker
$TLSA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
9
ISIN
BMG889121031
Website
TLSA Metrics
BasicAdvanced
$162M
-
-$0.11
0.13
-
Price and volume
Market cap
$162M
Beta
0.13
52-week high
$1.91
52-week low
$0.73
Average daily volume
435K
Financial strength
Current ratio
1.022
Quick ratio
1.002
Total debt to equity
2.693
Management effectiveness
Return on assets (TTM)
-84.13%
Return on equity (TTM)
-250.49%
Valuation
Price to book
41.06
Price to tangible book (TTM)
41.06
Price to free cash flow (TTM)
-100.117
Growth
Earnings per share change (TTM)
-35.58%
3-year earnings per share growth (CAGR)
-22.52%
TLSA News
AllArticlesVideos
Tiziana Life Sciences' foralumab reduced neuroinflammation in Alzheimer's patient, study shows
Proactive Investors·21 hours ago
Tiziana Life Sciences reports reduced brain inflammation in Alzheimer's patient treated with nasal foralumab
Proactive Investors·7 days ago
Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab
GlobeNewsWire·7 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Tiziana Life Sciences Ltd. stock?
Tiziana Life Sciences Ltd. (TLSA) has a market cap of $162M as of May 16, 2025.
What is the P/E ratio for Tiziana Life Sciences Ltd. stock?
The price to earnings (P/E) ratio for Tiziana Life Sciences Ltd. (TLSA) stock is 0 as of May 16, 2025.
Does Tiziana Life Sciences Ltd. stock pay dividends?
No, Tiziana Life Sciences Ltd. (TLSA) stock does not pay dividends to its shareholders as of May 16, 2025.
When is the next Tiziana Life Sciences Ltd. dividend payment date?
Tiziana Life Sciences Ltd. (TLSA) stock does not pay dividends to its shareholders.
What is the beta indicator for Tiziana Life Sciences Ltd.?
Tiziana Life Sciences Ltd. (TLSA) has a beta rating of 0.13. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.